Delivery Order SPE2DB22D1106-SPE2DB25FFCU4
- Not listed
- The Defense Logistics Agency awarded a $14,147.64 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical and wound care applications. The contract, executed on November 14, 2025, with an ultimate completion date of November 17, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company...
- The Defense Logistics Agency awarded a $43.7K delivery order to AmerisourceBergen Drug Corp on October 17, 2025, for the supply of 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This firm fixed-price delivery order, with completion targeted for October 20, 2025, was competitively awarded without set-aside designation and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a child contract...
- The Defense Logistics Agency awarded a delivery order valued at approximately $81,912 to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This firm fixed-price, non-set-aside contract was awarded on November 20, 2025, with an ultimate completion date of November 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order for 20,000 unit vials of Recothrom (thrombin topical), a hemostatic agent used in surgical applications. This firm fixed-price delivery order, valued at $7,567.75, was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a $7,476.11 delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical and wound care applications. This competitively awarded, firm fixed-price delivery order was issued on September 17, 2025, with an ultimate completion date of September 18, 2025, and represents a non-set-aside procurement. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $3,456 to Amerisourcebergen Drug Corporation. The order is for 20,000 units of Recothrom thrombin recombinant topical (Baxter) to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 18, 2023 in support of the Defense Logistics Agency's medical supply needs. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as...
- The Defense Logistics Agency Troop Support Medical awarded a $31,349 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 20,000 units of Recothrom vials. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from July 17, 2023 through July 18, 2023 to supply the critical blood clotting agent to support the medical readiness programs of the Department of Defense. No subcontractors...
- The Defense Logistics Agency awarded a $2,603 delivery order to Amerisourcebergen Drug Corporation for 20,000 units of Recothrom thrombin recombinant topical hemostatic agent. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance taking place from July 7-10, 2023. No set aside designation or subcontractors were identified. The Defense Logistics Agency supports America's armed forces by procuring nearly $20 billion worth of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $8,154.79 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 20,000 unit vials of the pharmaceutical product RECOTHROM, with a completion date of September 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous Indefinite Delivery Contracts (IDCs) by DLA and other federal agencies, valued up to $999,999,999,...
- Amerisourcebergen Drug Corp has received a $1,197.69 firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical to supply 5,000 units of Thrombin-JMI vials. Performance will take place at Amerisourcebergen's Conshohocken, Pennsylvania facility, with all supplies delivered by October 26, 2023. The delivery order was awarded against an indefinite delivery contract held by Amerisourcebergen Drug Corp to provide pharmaceuticals and medical supplies to various DLA Troop...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFCU4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 5,000 unit vials of Recothrom, a pharmaceutical product used in surgical hemostasis. This firm fixed-price delivery order, valued at $2,567.33, was competitively awarded without set-aside designation and is scheduled for completion by August 13, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a broad range of medications, vaccines, and medical devices to support military and veteran healthcare systems worldwide. The company's role as a prime vendor through this IDC enables efficient fulfillment of recurring pharmaceutical needs across the Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/12/25 |